- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03372226
Computer-based Self-Help Program for People With Gambling Problems
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Hamburg, Alemanha, 20246
- University Medical Center Hamburg-Eppendorf
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- informed consent
- access to internet
- adequate usage of German language
- willingness to participate in two short (25-30 minutes) online surveys
- willingness to use the online program over a period of 8 weeks (participants that do not use the program are also included in the analysis)
- willingness to leave an (anonymous) email-address
- existence of the wish to receive treatment
Exclusion Criteria:
- existence of a lifetime diagnosis of schizophrenia or bipolar disorder
- existence of an acute suicidal tendency (assessed with item 9 of the PHQ-9, ≥3)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Online self-help program
The intervention group receives the login data for the online program directly following the baseline assessment. The program consists of 10 modules with many interactional exercises and homework-sheets. Themes that are addressed in the online-program are for example self-esteem, sleep hygiene, problem solving strategies, mindfulness-based relaxation and attention exercises as well as gambling-specific topics such as money/debt management and impulse control. In addition, the user learns to modify negative and gambling-specific thought distortions, to integrate positive activities into his/her daily routine, strategies to deal with the urge to play as well as ways to regulate debts and to prevent relapse. |
The program consists of 10 modules with many interactional exercises and homework-sheets.
Themes that are addressed in the online-program are for example self-esteem, sleep hygiene, problem solving strategies, mindfulness-based relaxation and attention exercises as well as gambling-specific topics such as money/debt management and impulse control.
In addition, the user learns to modify negative and gambling-specific thought distortions, to integrate positive activities into his/her daily routine, strategies to deal with the urge to play as well as ways to regulate debts and to prevent relapse.
Outros nomes:
|
|
Sem intervenção: Wait-list control group
The participants of the wait-list control condition do not receive any new intervention during the intervention period of 8 weeks, but may continue any treatment that has already been started before, including medication.
Participants in the wait-list control condition receive full access to the program after completion of the post-assessment.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pathological Gambling Adaptation of Yale-Brown Obsessive Compulsive Scale (PG-Y-BOCS)
Prazo: 1 week
|
The total score consists of ten items that measure the severity of gambling symptoms within the past week.
The first five questions assess urges and thoughts associated with gambling, whereas the last five questions assess the behavioral component of the disorder.
The sum score of each subscale ranges from 0-20.
Each subscale can be analyzed separately as well as together as a total score (primary outcome).
The total score can be interpreted as follows: 0-7 sub-clinical, 8-15 mild, 16-23 moderate, 24-31 severe and 32-40 extreme gambling symptoms.
|
1 week
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Patient Health Questionnaire - 9 depression module (PHQ-9)
Prazo: 1 week
|
The Patient Health Questionnaire - 9 depression module is a self-rating measure of depressive symptom severity.
The psychometric properties of the PHQ-9 are very good, with high internal consistency (Cronbach's α = .86
- .89;
Kroenke, Spitzer, & Williams, 2001).
Its sum score ranges from 0 to 27, with scores from 0-4 indicating minimal depression, 5-9 mild depression, 10-14 moderate depression and 15-27 severe depression.
|
1 week
|
|
Gambling Attitudes and Beliefs Survey (GABS)
Prazo: time of assessment
|
The GABS is a self-report questionnaire which explores gambling-related dysfunctional beliefs.
In this study, we use a 15-item version of the GABS.
Responses can be given on a four-point Likert scale (from 'strongly agree' to 'strongly disagree').
|
time of assessment
|
|
South Oaks Gambling Screen (SOGS)
Prazo: 6 months
|
20-items self-report measure to screen for engagement in gambling activities and gambling-related problems.
A score between 0-2 corresponds to non-problematic gambling, a score of 3-4 to at-risk gambling, and a score of 5-20 to probable pathological gambling.
|
6 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Steffen Moritz, Prof. Dr., Universitätsklinikum Hamburg-Eppendorf
Publicações e links úteis
Publicações Gerais
- Gehlenborg J, Moritz S, Bücker L. The Dimensional Structure of the Gambling Attitudes and Beliefs Survey: Challenging the Assumption of the Unidimensionality of Gambling-Specific Cognitive Distortions. J Gambl Stud. 2022 May 28. doi: 10.1007/s10899-022-10133-7. [Epub ahead of print]
- Bucker L, Gehlenborg J, Moritz S, Westermann S. A randomized controlled trial on a self-guided Internet-based intervention for gambling problems. Sci Rep. 2021 Jun 22;11(1):13033. doi: 10.1038/s41598-021-92242-8.
- Bucker L, Westermann S, Kuhn S, Moritz S. A self-guided Internet-based intervention for individuals with gambling problems: study protocol for a randomized controlled trial. Trials. 2019 Jan 23;20(1):74. doi: 10.1186/s13063-019-3176-z.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Neustart
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .